Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| B cell | 21 studies | 29% ± 10% | |
| fibroblast | 20 studies | 25% ± 7% | |
| astrocyte | 18 studies | 46% ± 21% | |
| mast cell | 15 studies | 21% ± 5% | |
| epithelial cell | 12 studies | 33% ± 16% | |
| naive B cell | 11 studies | 25% ± 9% | |
| macrophage | 11 studies | 25% ± 9% | |
| GABAergic neuron | 9 studies | 40% ± 23% | |
| memory B cell | 9 studies | 25% ± 8% | |
| endothelial cell | 9 studies | 26% ± 8% | |
| glutamatergic neuron | 9 studies | 45% ± 25% | |
| oligodendrocyte precursor cell | 9 studies | 33% ± 17% | |
| type I pneumocyte | 8 studies | 24% ± 6% | |
| adipocyte | 8 studies | 28% ± 14% | |
| smooth muscle cell | 7 studies | 22% ± 6% | |
| basal cell | 7 studies | 34% ± 12% | |
| enterocyte | 6 studies | 27% ± 5% | |
| dendritic cell | 6 studies | 26% ± 18% | |
| ciliated cell | 6 studies | 22% ± 2% | |
| type II pneumocyte | 6 studies | 24% ± 6% | |
| erythrocyte | 6 studies | 30% ± 9% | |
| secretory cell | 5 studies | 29% ± 8% | |
| conventional dendritic cell | 5 studies | 35% ± 13% | |
| microglial cell | 5 studies | 27% ± 9% | |
| club cell | 5 studies | 30% ± 10% | |
| cardiac muscle cell | 5 studies | 59% ± 15% | |
| hepatocyte | 5 studies | 51% ± 22% | |
| interneuron | 5 studies | 46% ± 25% | |
| duct epithelial cell | 4 studies | 31% ± 13% | |
| mononuclear phagocyte | 4 studies | 34% ± 3% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 19% ± 2% | |
| non-classical monocyte | 4 studies | 25% ± 10% | |
| neuron | 4 studies | 29% ± 8% | |
| transit amplifying cell | 4 studies | 20% ± 3% | |
| myeloid cell | 4 studies | 25% ± 6% | |
| monocyte | 4 studies | 20% ± 3% | |
| mucus secreting cell | 4 studies | 42% ± 18% | |
| luminal hormone-sensing cell of mammary gland | 4 studies | 48% ± 11% | |
| abnormal cell | 4 studies | 34% ± 12% | |
| brush cell | 4 studies | 26% ± 7% | |
| myofibroblast cell | 4 studies | 20% ± 2% | |
| classical monocyte | 3 studies | 32% ± 7% | |
| intestinal crypt stem cell | 3 studies | 30% ± 7% | |
| GABAergic interneuron | 3 studies | 24% ± 6% | |
| serous secreting cell | 3 studies | 32% ± 11% | |
| glial cell | 3 studies | 23% ± 7% | |
| lymphocyte | 3 studies | 20% ± 4% | |
| gamma-delta T cell | 3 studies | 26% ± 6% | |
| muscle cell | 3 studies | 38% ± 20% | |
| enteroendocrine cell | 3 studies | 20% ± 3% | |
| goblet cell | 3 studies | 41% ± 14% | |
| Schwann cell | 3 studies | 47% ± 17% | |
| granule cell | 3 studies | 23% ± 4% | |
| oligodendrocyte | 3 studies | 19% ± 4% | |
| plasmacytoid dendritic cell | 3 studies | 20% ± 2% | |
| progenitor cell of mammary luminal epithelium | 3 studies | 25% ± 6% | |
| luminal cell of prostate epithelium | 3 studies | 22% ± 7% | |
| renal principal cell | 3 studies | 31% ± 9% | |
| connective tissue cell | 3 studies | 17% ± 2% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 11 studies | 36% ± 19% | |
| lung | 6 studies | 19% ± 4% | |
| liver | 5 studies | 39% ± 23% | |
| intestine | 5 studies | 20% ± 6% | |
| heart | 4 studies | 33% ± 5% | |
| breast | 4 studies | 24% ± 6% | |
| peripheral blood | 3 studies | 27% ± 5% | |
| adipose | 3 studies | 23% ± 7% | |
| prostate | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 100% | 2697.85 | 2636 / 2642 | 100% | 33.15 | 702 / 705 |
| prostate | 100% | 3429.06 | 245 / 245 | 99% | 29.05 | 496 / 502 |
| intestine | 100% | 3601.71 | 966 / 966 | 99% | 33.21 | 520 / 527 |
| stomach | 100% | 3529.63 | 359 / 359 | 99% | 32.17 | 282 / 286 |
| skin | 100% | 2449.18 | 1802 / 1809 | 98% | 31.84 | 463 / 472 |
| liver | 100% | 3719.54 | 226 / 226 | 98% | 41.59 | 396 / 406 |
| breast | 100% | 5406.55 | 459 / 459 | 97% | 46.16 | 1089 / 1118 |
| kidney | 100% | 2804.10 | 89 / 89 | 94% | 21.72 | 847 / 901 |
| thymus | 100% | 3366.66 | 653 / 653 | 94% | 55.41 | 566 / 605 |
| lung | 100% | 3789.70 | 578 / 578 | 90% | 17.28 | 1045 / 1155 |
| adrenal gland | 100% | 3874.94 | 258 / 258 | 89% | 22.45 | 205 / 230 |
| pancreas | 90% | 984.84 | 294 / 328 | 96% | 20.87 | 171 / 178 |
| ovary | 100% | 1951.08 | 180 / 180 | 85% | 12.98 | 365 / 430 |
| esophagus | 99% | 2491.93 | 1433 / 1445 | 85% | 18.02 | 155 / 183 |
| bladder | 100% | 3091.33 | 21 / 21 | 82% | 20.39 | 415 / 504 |
| uterus | 100% | 2347.92 | 170 / 170 | 74% | 11.71 | 338 / 459 |
| adipose | 100% | 3503.24 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2268.13 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3038.78 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 99% | 30.08 | 79 / 80 |
| peripheral blood | 98% | 3564.31 | 914 / 929 | 0% | 0 | 0 / 0 |
| muscle | 98% | 1686.62 | 783 / 803 | 0% | 0 | 0 / 0 |
| heart | 95% | 4881.35 | 819 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 80% | 16.65 | 36 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 55% | 5.44 | 16 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006656 | Biological process | phosphatidylcholine biosynthetic process |
| GO_0006629 | Biological process | lipid metabolic process |
| GO_0001558 | Biological process | regulation of cell growth |
| GO_0006663 | Biological process | platelet activating factor biosynthetic process |
| GO_0006657 | Biological process | CDP-choline pathway |
| GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0016020 | Cellular component | membrane |
| GO_0005789 | Cellular component | endoplasmic reticulum membrane |
| GO_0004142 | Molecular function | diacylglycerol cholinephosphotransferase activity |
| GO_0019992 | Molecular function | diacylglycerol binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | CHPT1 |
| Protein name | Choline phosphotransferase 1 Cholinephosphotransferase 1 (hCPT1) (EC 2.7.8.2) (AAPT1-like protein) (Diacylglycerol cholinephosphotransferase 1) Cholinephosphotransferase 1 (EC 2.7.8.2) (Diacylglycerol cholinephosphotransferase 1) |
| Synonyms | MSTP022 CPT1 |
| Description | FUNCTION: Catalyzes the final step of de novo phosphatidylcholine (PC) synthesis, i.e. the transfer of choline phosphate from CDP-choline to the free hydroxyl of a diacylglycerol (DAG), producing a PC. It thereby plays a central role in the formation and maintenance of vesicular membranes. . |
| Accessions | H0YI84 H0YHV7 ENST00000549128.5 ENST00000229266.8 [Q8WUD6-1] ENST00000549872.5 H0YI24 Q8WUD6 ENST00000546873.1 F8W1B3 ENST00000552329.1 ENST00000552215.5 ENST00000552351.5 [Q8WUD6-2] |